Red light therapy is usually associated with skincare, muscle recovery and pain relief.

But one of the most interesting areas of photobiomodulation is developing above the neck.

Researchers are studying whether controlled red and near-infrared light can support attention, working memory, learning and mental recovery. At the same time, consumer neurotechnology brands are exploring headbands, helmets and headphones that bring brain-focused photobiomodulation into everyday environments.

The opportunity is significant. So is the risk of oversimplification.

The current evidence does not show that a short light session can instantly make someone more intelligent. It does suggest that transcranial photobiomodulation may support biological processes involved in cognitive performance, particularly cellular energy production and prefrontal oxygenation.

For brands and OEMs, understanding that distinction is essential.

What do we mean by cognitive performance?

Cognitive performance is a broad term. It describes several mental abilities rather than one single outcome.

These include:

• Attention and concentration
• Working memory
• Learning
• Reaction time
• Decision-making
• Impulse control
• Executive function
• Mental endurance

A light therapy device may influence one area without producing measurable effects in another.

For example, a study may find improvements in sustained attention but no change in a different type of learning. Another may report stronger working-memory performance in a specific population while offering no evidence for healthy users more broadly.

This is why claims such as “boosts brain performance” are too vague on their own.

A credible product should define the cognitive function it intends to support and ensure that the technology, protocol and evidence align with that objective.

For a broader introduction to brain-focused applications, read Photobiomodulation for Brain Health: How Light Supports Cognitive Function.

Is it really red light therapy?

In consumer language, “red light therapy” is often used as an umbrella term covering both visible red light and invisible near-infrared light.

That distinction matters for brain-focused devices.

Visible red wavelengths are absorbed more strongly in superficial tissues. Near-infrared wavelengths generally penetrate more deeply, making them more relevant when the target sits beneath the scalp and skull.

Many of the human studies exploring cognitive performance have therefore used near-infrared wavelengths rather than visible red light alone. Common research wavelengths include approximately 810 and 1064 nanometres.

This does not mean visible red light has no biological value. It means that a transcranial device needs to be designed around the depth and location of the intended target.

The practical differences are explained further in Red Light vs Near-Infrared (NIR): When to Use Which, and Why.

How photobiomodulation may support cognition

The brain requires a continuous supply of energy.

Neurons need ATP to maintain electrical gradients, release neurotransmitters and communicate across neural networks. Cognitive tasks involving attention, memory and decision-making increase demand within specific brain regions.

Photobiomodulation may support this system through several connected pathways.

Mitochondrial energy production

Red and near-infrared light can interact with cellular photoacceptors and signalling pathways. Cytochrome c oxidase, an enzyme involved in mitochondrial respiration, is frequently identified as an important target.

This may support more efficient ATP production and give metabolically active cells additional resources for normal function.

The mechanism is explored in more detail in Photobiomodulation and Mitochondrial Health: The Foundation of PBM.

Cerebral oxygenation and circulation

Photobiomodulation may also influence nitric oxide signalling and local blood flow.

In a human study involving active stimulation of the right prefrontal cortex, researchers observed increased prefrontal oxygenation alongside improvements in sustained attention and working-memory performance. The findings connected the cognitive effects of transcranial light exposure with measurable haemodynamic changes in the targeted brain region.

Redox and cellular signalling

PBM does not simply eliminate reactive oxygen species. Instead, it may modulate redox signalling in ways that activate adaptive cellular responses.

Within an appropriate dose range, these responses may support resilience, repair and more efficient cellular communication.

The outcome depends heavily on the state of the tissue and the energy delivered. More light does not automatically create a stronger response.

Why the prefrontal cortex is commonly targeted

Many cognitive PBM studies apply light to the forehead.

This provides relatively direct access without hair blocking the treatment area. It also positions the light over the prefrontal cortex, a region involved in attention, planning, working memory, decision-making and impulse control.

Targeting the prefrontal cortex does not mean all light reaches that region. Energy is lost through reflection, absorption and scattering within the skin, blood, connective tissue and skull.

However, the forehead offers a practical route for controlled research and wearable product development.

This is one reason many commercial concepts use forehead applicators or headbands rather than attempting to illuminate the full scalp equally.

What studies in healthy adults have found

Some of the clearest early cognitive findings come from controlled experiments in healthy adults.

A randomized study involving 118 participants investigated the effect of transcranial infrared laser stimulation on two forms of category learning. Stimulation of the lateral prefrontal cortex improved rule-based learning, which relies more heavily on explicit cognitive strategies, but did not significantly improve the information-integration task.

This is a useful example of why “cognitive enhancement” should not be treated as one universal effect.

The intervention appeared to support a particular cognitive system linked to the targeted brain region. It did not improve every type of learning.

Another study examined cognitive performance and prefrontal oxygenation after transcranial photobiomodulation. Active treatment was associated with stronger cerebrovascular oxygenation during sustained attention and working-memory tasks compared with sham controls.

Together, these studies suggest that tPBM may influence specific prefrontal functions. They do not establish a standard consumer treatment for general intelligence, creativity or productivity.

New evidence in attention and impulse control

A randomized controlled study published in 2026 examined acute 1064 nm transcranial photobiomodulation applied to the right prefrontal cortex.

The study included adults with and without ADHD. Within the ADHD group, active stimulation was associated with improved correct rejections during a continuous performance task compared with sham treatment. The researchers also observed increased prefrontal oxygenation and selected improvements in working-memory performance.

No adverse events were reported in the study, but the authors emphasized the need for repeated-session research and further validation.

This study strengthens the case for continued research into attention and impulse control.

It does not mean a general consumer headset can claim to treat ADHD. Medical claims require evidence for the specific device, protocol, target population and intended use.

What about memory and cognitive decline?

Research is also exploring photobiomodulation in populations experiencing cognitive impairment.

A 2023 systematic review and meta-analysis assessed 11 randomized controlled trials involving age-related cognitive impairment. The pooled results suggested a moderate effect on global cognitive function, but outcomes differed according to wavelength strategy, light source, device type, treatment method and cumulative exposure time.

These findings are encouraging, but the variation between studies is important.

Some interventions used lasers. Others used LEDs. Some combined multiple wavelengths or treatment routes. Treatment duration and session frequency also differed.

The results therefore support the potential of PBM as a category. They do not prove that all brain-light devices are equally effective.

A 2025 proof-of-concept study using an 810 nm LED headset and intranasal applicator reported improvements across selected measures of attention, memory and executive function in participants with a history of repetitive head acceleration events. However, the study lacked the stronger randomized, sham-controlled design required to confirm treatment efficacy.

Does one treatment produce an immediate effect?

Some cognitive studies investigate the effect of a single session. Others use repeated treatments over several weeks.

These approaches answer different questions.

An acute study may examine whether one controlled exposure changes performance during a task. A repeated-session study may explore longer-term adaptation, recovery or neurological support.

A short-term effect does not automatically predict long-term benefit. Likewise, a protocol designed for repeated use should not assume that increasing session frequency will produce faster results.

OEMs need to determine whether the product is designed for:

• Occasional cognitive preparation
• Daily mental-performance routines
• Post-work cognitive recovery
• Long-term brain wellness
• Professional or supervised treatment

That decision affects dose, session length, hardware requirements and the evidence strategy.

Why dose matters as much as wavelength

Selecting 810 or 1064 nm does not create an effective cognitive device by itself.

The biological exposure also depends on:

• Irradiance
• Treatment duration
• Total applied energy
• Treatment area
• Distance from the scalp
• Continuous or pulsed delivery
• Optical contact
• User anatomy

PBM is associated with a biphasic dose response. Too little energy may fail to produce a meaningful effect. Increasing exposure beyond the useful range may lead to diminishing or different responses.

This makes dose optimization essential.

The applied dose at the skin is also not the same as the dose reaching cortical tissue. Much of the energy is lost before it reaches the brain.

Understanding Joules per cm²: The Science of Optimal Light Therapy Dosing explains how irradiance, time and treatment geometry work together.

LEDs and lasers are not interchangeable

Human cognitive studies have used both LEDs and lasers.

Lasers offer directional output and can deliver concentrated energy to a defined area. LEDs are easier to integrate into consumer wearables and can distribute light across a broader treatment surface.

Neither option is automatically superior for every application.

A result obtained with a 1064 nm laser cannot simply be transferred to an 850 nm LED headband. The wavelength, beam profile, irradiance, dose and treatment location may all differ.

For consumer products, LEDs often offer practical advantages around size, cost, coverage and scalable manufacturing. However, the finished optical system must still recreate the treatment conditions needed for the intended outcome.

A large number of LEDs does not compensate for weak positioning or inconsistent output.

Hair, fit and anatomy influence performance

Hair can block or scatter light before it reaches the scalp.

A forehead-based product avoids much of this issue. Devices targeting other parts of the head need to account for differences in hair density, colour and styling.

Fit also influences optical delivery.

When emitters move away from the intended location, the distance and angle change. A loose headset may deliver an inconsistent dose. An overly tight system may improve contact but become uncomfortable.

This is why ergonomic design is part of treatment performance, not merely an aesthetic consideration.

The wider product-development implications are discussed in How Light Therapy Is Powering the Next Generation of Cognitive Wearables.

Cognitive performance also depends on timing

Attention and mental energy change throughout the day.

Circadian rhythm, sleep pressure, recent workload and recovery all influence cognitive performance. This means the same person may respond differently depending on when a session takes place.

A device intended for morning focus may require a different experience from one designed for evening recovery.

PBM should not be confused with conventional bright-light therapy, which primarily influences circadian timing through the eyes. However, cognitive-wellness platforms may eventually combine environmental light guidance, sleep data and transcranial PBM within one connected system.

The relationship between brain function and daily biological timing is explored in Light, Time, and Your Brain: How Photobiomodulation Tunes Your Circadian Rhythm.

What the science does not yet prove

Current research does not support every claim made around brain-light products.

It does not show that one universal wavelength works for everyone. It does not establish a single optimal dose. It does not prove that a consumer PBM wearable can replace sleep, breaks, medical treatment or evidence-based cognitive training.

The evidence base also contains important limitations:

• Many studies use relatively small samples
• Devices and protocols differ significantly
• Some studies assess only one treatment
• Long-term outcomes remain less clear
• Results from medical populations cannot automatically be applied to healthy consumers
• Findings from lasers cannot be transferred directly to every LED product

This does not make the field unpromising.

It means product developers need to distinguish between scientific potential and commercially proven outcomes.

What this means for OEMs

A brain-focused light therapy product should begin with a specific cognitive objective.

“Supports cognitive performance” is still too broad for engineering and validation. A stronger starting point may be:

• Supporting sustained attention during defined tasks
• Supporting mental recovery after cognitive work
• Supporting healthy working-memory function
• Supporting an evening brain-wellness routine
• Delivering a research-aligned prefrontal PBM protocol

Once the objective is clear, teams can define the treatment area, wavelength, applied dose, session duration and intended user.

The claims should be developed at the same time.

A general wellness product follows a different path from a device claiming to treat ADHD, dementia, depression or cognitive impairment. Stronger claims create stronger requirements for clinical evidence, risk management and regulatory approval.

Clinical Evidence and Claims: What Light Therapy Brands Need to Know explains why claim strategy needs to begin before the final device is built.

Building a credible cognitive PBM product

The most credible products will not be those with the largest number of treatment modes.

They will be the products that deliver one clearly defined protocol consistently.

That requires coordination across:

• Scientific research
• Optical engineering
• Electronics and firmware
• Industrial design
• Thermal management
• Software
• Usability testing
• Regulatory strategy
• Controlled manufacturing

The system must deliver the intended wavelength and dose under real-use conditions. It must fit a range of users, remain comfortable and communicate its purpose without overstating the science.

For a broader overview of the category, read What Are Cognitive Wearables? A Complete Guide for OEMs.

Conclusion

Early human research suggests that transcranial photobiomodulation may support selected areas of cognitive performance, including attention, working memory, rule-based learning and impulse control.

The strongest findings are connected to specific wavelengths, treatment locations and study protocols. They cannot be generalized to every red light therapy product.

For brands, the opportunity lies in turning a promising biological mechanism into a controlled and credible device. That means selecting the right wavelength, engineering the dose, targeting the correct region and keeping claims proportionate to the available evidence.

At Light Tree Technology, we help brands develop brain-focused and wearable photobiomodulation devices from initial research through optical engineering, prototyping, validation, regulatory preparation and scalable production.

Looking to develop a cognitive-performance light therapy device?

Build the treatment protocol and product architecture around the evidence from the beginning.

Start your project with Light Tree Technology.

‍